Skip to main content
. 2021 Apr 11;45(7):2218–2226. doi: 10.1007/s00268-021-06073-9

Table 4.

Correlation of variables for major postoperative complications in univariate and multivariate analysis (values in bold-italic indicate significance at p < 0.05)

None/minor complications (n =) Major complications (n =) Univariate analysis Log regression analysis
(Odds ratio, CI 95%)

VAT ≤ 100 cm2

VAT ≥ 100 cm2

23

36

5

30

p = .019 p = .004 (OR 1.4, CI 1.1–1.7)

VAT ≤ 168 cm2/80cm2

VAT ≥ 168 cm2/80 cm2

26

33

10

25

p = .188 p = .095 (OR 1.2, CI 0.8–1.4)

V/S ≤ 0.4

V/S ≥ 0.4

15

44

4

31

p = .119 p = .072 (OR 1.2, CI 0.9–1.5)

BMI < 30 kg/m2

BMI > 30 kg/m2

51

8

28

7

p = .561 p = .190 (1.2, CI 0.9–1.6)

No sarcopenia

sarcopenia

39

20

21

14

p = .658 p = .068 (OR 1.2, CI 0.9–1.5)

No sarcopenic obesity

Sarcopenic obesity

52

7

24

11

p = .029 p = .051 (OR 1.3, CI 1.9–1.7)

Male

Female

32

27

26

9

p = .079

Minor hepatectomy

Major hepatectomy

36

23

22

13

p = .859 p = .779 (OR 1.0, CI 0.9–1.2)

Minor hepatectomy +  ≥ Vat 100 cm2

Major hepatectomy +  ≥ VAT 100 cm2

22

14

19

11

p = .853

No art. hypertension

Art. hypertension

44

15

20

15

p = .080 p = .670 (OR 1.1, CI 0.8–1.3)

No CVD

Cardiovascular disease

54

5

24

11

p = .009 p = .113 (OR 1.2, CI 0.9–1.7)

No diabetes mellitus

Diabetes mellitus

51

8

30

5

p = 1.0

No neoadj CTx

Neoadj. CTx

20

39

15

20

p = .385

No neoadj CTx + sarcopenia

Neoadj CTx + sarcopeniaenia

12

8

9

5

p = 1.0